Regenera Pharma

Israeli clinical-stage pharmaceutical company developing innovative drugs for optic nerve neuropathies. Lead drug RPh201 is an extract from mastic gum (botanical source) that stimulates new neuron and synapse formation. In Phase 3 for NAION and Phase 2 for Alzheimer's disease. Based in Ness Ziona.